skip to Main Content
I-MED Pharma Partners with Iogen Oy to Introduce I-DROP®, I-LID ’N LASH®,  I-RELIEFTM Therapeutic Eye Mask and the I-PEN® Osmolarity System to the Finnish Market.

I-MED Pharma Partners with Iogen Oy to Introduce I-DROP®, I-LID ’N LASH®, I-RELIEFTM Therapeutic Eye Mask and the I-PEN® Osmolarity System to the Finnish Market.

MONTREAL, November 1st, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…

read more
I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the U.S Market.

I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the U.S Market.

I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the…

read more
I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg & the Netherlands

I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg & the Netherlands

I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg &…

read more
Quebec Government Supports I-MED Pharma by Helping Fund International Expansion

Quebec Government Supports I-MED Pharma by Helping Fund International Expansion

West Island businesses get financial boost from Quebec Government The Quebec government is giving several…

read more
I-MED Pharma Inc. Announces Partnership with Medicals International

I-MED Pharma Inc. Announces Partnership with Medicals International

MONTREAL, July 23, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…

read more
I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada

I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada

Montreal, May 24, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in…

read more

I-MED Pharma’s I-PEN® Receives Regulatory Approval from INVIMA in Colombia and ANMAT in Argentina  

Montreal, April 3, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian Company specializing in…

read more

I-MED Pharma’s I-PEN® Does Not Infringe the TearLab Patent

Montreal, February 20, 2018 (GLOBE NEWSWIRE) – On February 14th TearLab issued a press release…

read more

I-MED Pharma Wins Patent Case Against TearLab

Montreal, February 13, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., announced today that TearLab’s efforts…

read more

I-MED Pharma partners with OCuSOFT to bring the I-PEN® Osmolarity System to the U.S.A.

Montreal, January 8, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in…

read more

I-PEN®and I-PLUG® now available in Spain and Portugal through Partnership with IMEX

MONTREAL, January 8, 2018 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in…

read more
Back To Top